Reverse transcriptase inhibitors

Use of the reverse transcriptase enzyme is a unique characteristic of retroviruses such as HIV. After the virus releases its genetic material into a host cell, reverse transcriptase converts the viral RNA into a complementary piece of DNA, a process is known as ‘reverse transcription’.

Reverse transcriptase works by looking in turn at each of the nucleoside building blocks that make up the viral RNA and using them as a template to assemble a complementary DNA chain using nucleotide building blocks present in the cell.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.